News

not found

Startup’s Oxygen-Boosting ‘Artificial Lung’ Receives US Patent

Inspira Technologies has developed a machine that can raise a patient's oxygen saturation to 95 percent or higher almost immediately (Courtesy) A new device developed by an Israeli startup that helps patients breathe when their lungs are unable to do so fully has just been patented in the US. The INSPIRA ART500, produced by Inspira Technologies, is a small box-shaped device that acts as an artificial lung. It draws small volumes of blood with low oxygen levels from patients and circulates it, enriches it with oxygen and removes carbon dioxide, and sends it back through a tube inserted into the neck.  The startup has developed the device with the aim of reducing the need for mechanical ventilation systems. According to the company, these systems are associated with a 50 percent mortality rate, can heighten the risk of coma and even cause bacterial infections or other associated lung injuries related to mechanical ventilation.  The newly granted patent relates to the module of the machine that prevents air bubbles within its pumps, thereby reducing the risk of the formation of clots which reduce blood flow.  Inspira has also initiated patent applications in Europe and several countries in other regions. “We believe that this patent approval represents a further recognition of our unique solution alongside a major milestone towards the INSPIRA ART500 system and building a global medical solution,” said Dagi Ben-Noon, CEO of Inspira. “We are working diligently to convert our innovation into value for our shareholders.”

  • 6 November, 12:50
  • Read more
not found

Cooperation with Afghanistan in the field of pharmaceuticals will expand

The delegation led by the Deputy Prime Minister of Uzbekistan Jamshid Khodjaev visited Kabul to further develop cooperation with the Islamic Emirate of Afghanistan.The "Made in Uzbekistan" exhibition organized at the International Business Center was attended by a group of industry officials under the leadership of Abdulla Azizov, director of the Pharmaceutical Industry Development Agency. More than 300 medical products were displayed. Also, meetings and negotiations were held in "B2B" format between representatives of the business circles of the two countries. About 4,000 medical products were presented at the exhibition.Director of the Pharmaceutical Service of the Ministry of Health of Afghanistan, Hamid Formuloy, made suggestions on simplifying the registration of the delivery of pharmaceuticals and products produced in Uzbekistan to Afghanistan.In this matter, practical assistance will be provided to establish cooperation with the National Association of Food and Medicines of Afghanistan, which has the authority to register medical products.Within the framework of the meetings, the issue of importing medicines, medical equipment and medical equipment from our country to private hospitals in this country and sending patients to Uzbekistan for treatment was discussed with the deputy of the Afghanistan Entrepreneurs' Advisory Council for health issues, Dr. Muhammad Hashim Wahaaj. Also, an agreement was reached on the visit of the Afghan delegation in order to get acquainted with medical products and treatment processes in Uzbekistan. Export-import issues were discussed with Zabihullah Momen Zada, a member of the Kabul Chamber of Commerce and Industry.

  • 31 October, 11:07
  • Read more
not found

AI can detect diabetes — just by listening to you talk for 10 seconds: new study

New medical research finds that artificial intelligence can detect type 2 diabetes merely by listening to a patient speak for six to ten seconds. The study by Klick Labs, published in “Mayo Clinic Proceedings: Digital Health,” showed an 89% accuracy rate for diagnoses in women and 86% for men, according to a release detailing the breakthrough. “Our research highlights significant vocal variations between individuals with and without Type 2 diabetes and could transform how the medical community screens for diabetes,” said first author Jaycee Kaufman. “Current methods of detection can require a lot of time, travel, and cost. Voice technology has the potential to remove these barriers entirely,” Kaufman continued. Researcher had 267 individuals — who did or did not have type 2 diabetes — record phrases on their smartphones six times a day for two weeks. More than 18,000 recordings were analyzed for over 14 different acoustic features, which were different among diabetics and non-diabetics. Participants also provided basic health data like age, height, and weight. Signal processing technologies were able to perceive certain notes of vocal pitch that do not register with the human ear. These hidden sounds provided the necessary clues, according to Kaufman. “Our research underscores the tremendous potential of voice technology in identifying Type 2 diabetes and other health conditions,” Klick VP and principal investigator Yan Fossat said. “Voice technology could revolutionize healthcare practices as an accessible and affordable digital screening tool.” The next step for Klick is replicating the study and expanding the vocal search to look for pre-diabetes, hypertension and more.

  • 30 October, 12:20
  • Read more
Нажмите на кнопку ниже, чтобы прослушать текст Powered by GSpeech